Pharmacoproteomics of Obesity: Definitions, Role and a Case Study of Dynamics of Human Plasma Proteome
Author:
- 19 October 2011
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 12 (10) , 1363-1365
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Epigenetic Epidemiology of Common Complex Disease: Prospects for Prediction, Prevention, and TreatmentPLOS Medicine, 2010
- Dynamics of plasma proteome during leptin-replacement therapy in genetically based leptin deficiencyThe Pharmacogenomics Journal, 2010
- Proteomic Analysis for Antiobesity Potential of Capsaicin on White Adipose Tissue in Rats Fed with a High Fat DietJournal of Proteome Research, 2010
- Proteomic characterization of thiazolidinedione regulation of obese adipose secretome in Zucker obese ratsProteomics – Clinical Applications, 2009
- Plasma proteome analysis for anti‐obesity and anti‐diabetic potentials of chitosan oligosaccharides in ob/ob miceProteomics, 2009
- Proteomics in obesity researchProteomics – Clinical Applications, 2009
- In-depth Analysis of the Adipocyte Proteome by Mass Spectrometry and BioinformaticsMolecular & Cellular Proteomics, 2007
- Mass spectrometry–based proteomics turns quantitativeNature Chemical Biology, 2005
- Serum Immunoreactive-Leptin Concentrations in Normal-Weight and Obese HumansNew England Journal of Medicine, 1996
- Positional cloning of the mouse obese gene and its human homologueNature, 1994